Privia Health (PRVA) EPS (Weighted Average and Diluted) (2020 - 2025)
Privia Health has reported EPS (Weighted Average and Diluted) over the past 6 years, most recently at $0.07 for Q4 2025.
- Quarterly results put EPS (Weighted Average and Diluted) at $0.07 for Q4 2025, up 133.33% from a year ago — trailing twelve months through Dec 2025 was $0.17 (up 54.55% YoY), and the annual figure for FY2025 was $0.18, up 63.64%.
- EPS (Weighted Average and Diluted) for Q4 2025 was $0.07 at Privia Health, up from $0.05 in the prior quarter.
- Over the last five years, EPS (Weighted Average and Diluted) for PRVA hit a ceiling of $0.16 in Q4 2022 and a floor of -$1.68 in Q2 2021.
- Median EPS (Weighted Average and Diluted) over the past 5 years was $0.03 (2023), compared with a mean of -$0.07.
- Biggest five-year swings in EPS (Weighted Average and Diluted): crashed 2900.0% in 2021 and later surged 400.0% in 2023.
- Privia Health's EPS (Weighted Average and Diluted) stood at -$0.09 in 2021, then skyrocketed by 277.78% to $0.16 in 2022, then crashed by 81.25% to $0.03 in 2023, then changed by 0.0% to $0.03 in 2024, then surged by 133.33% to $0.07 in 2025.
- The last three reported values for EPS (Weighted Average and Diluted) were $0.07 (Q4 2025), $0.05 (Q3 2025), and $0.02 (Q2 2025) per Business Quant data.